ASIAN AMERICAN CHEMICAL DEPENDENCY TREATMENT SERVICE (EIN 810585942) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2002

Principal Officer

TAE SON LEE

Phone

2533023826

Tax Period

2024-01-01 to 2024-12-31

ASIAN AMERICAN CHEMICAL DEPENDENCY TREATMENT SERVICE, founded in 2002, is a community nonprofit in the Mental Health sector that reported $3.3M in total revenue in fiscal year 2024. Revenue grew 9% year-over-year, indicating healthy expansion. The organization ran a surplus of $755K, a strong 23% operating margin.

Mission

THE MISSION OF ACTS IS TO REACH OUT, ENGAGE AND PROVIDE CONSUMER CENTRIC CARE FOR THOSE IN COMMUNITY SUFFERING WITH SUBSTANCE USE DISORDERS, MENTAL ISSUE, GAMBLING ADDICTIONS, AND DOMESTIC VIOLENCE BEHAVIORS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $1,041,853

Program Service Revenue $2,205,773

Investment Income $71,131

Other Revenue $0

TOTAL REVENUE $3,318,757

Expense Breakdown

Grants Paid $1,000

Salaries & Benefits $1,598,828

Fundraising Expenses $0

Program Expenses $1,919,575

Other Expenses $964,045

TOTAL EXPENSES $2,563,873

Year-over-Year Comparison

	2024	2023	Change
Revenue	$3,318,757	$3,041,902	+0.1%
Expenses	$2,563,873	$2,612,421	0.0%
Net Income	$754,884	$429,481	+0.8%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

$626,166

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
TAE SON LEE	DIRECTOR	40.00	Key Emp	$342,700	$6,150	$348,850
SOON LEE-KIM	DIRECTOR	40.00	Key Emp	$271,250	$6,066	$277,316
NATHAN BROWN	GOVERNOR	N/A	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$3,318,757	$2,563,873	$4,278,455	$754,884
2023	$3,041,902	$2,612,421	$3,221,709	$429,481
2022	$2,927,726	$2,475,032	$2,830,423	$452,694
2021	$1,378,050	$1,488,154	$1,811,051	$-110,104
2020	$1,814,065	$1,277,413	$1,780,764	$536,652
2019	$1,322,590	$909,086	$1,214,845	$413,504
2018	$1,240,197	$822,945	$826,083	$417,252

ASIAN AMERICAN CHEMICAL DEPENDENCY TREATMENT SERVICE